Elexacaftor, tezacaftor and ivacaftor (ETI)

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Growth parameters and prematurity Preterm (< 37 weeks) Etherington, 2024 10.31[0.09; 1.05]1826not evaluable Maternal consequences Gestational diabetes Etherington, 2024 13.89[1.19; 12.68]2724not evaluable0.020.01.0